Delivery Order SPE2DU25D9809-SPE2DU26F0C83

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,028.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 10, 2025, falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Defense Logistics Agency acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group was awarded a single-award indefinite delivery contract under this initiative on November 13, 2025, with a ceiling value of $499.999 billion and a completion date of December 31, 2036, comprising a 30-month base period and three 30-month option periods. No set-aside designation was used for this delivery order.

DMS Pharmaceutical Group supplies a comprehensive product portfolio including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs across the military healthcare system. The company's demonstrated performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with previous awards ranging from under $100 to over $115,000, demonstrates its capability to fulfill the diverse pharmaceutical and medical consumable requirements essential to Department of Defense healthcare operations globally. This delivery order represents one of multiple procurement actions issued to the contractor to fulfill urgent or routine pharmaceutical supply needs under the broader PPV-G GEN V program.